2:I[6146,[],""]
3:I[4411,[],""]
4:"$Sreact.suspense"
5:I[7256,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"KeyboardNavigation"]
6:I[5407,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"SlideNavigation"]
0:["DkpgZd6XOJjDaY981EGFp",[[["",{"children":["pages",{"children":["9",{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",{"children":["pages",{"children":["9",{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white","children":["$","div",null,{"className":"flex flex-col w-full h-full","children":[["$","div",null,{"className":"flex-none bg-slate-800/90 p-6 flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":48,"height":48,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-compass text-purple-400","children":[["$","path","9ktpf1",{"d":"m16.24 7.76-1.804 5.411a2 2 0 0 1-1.265 1.265L7.76 16.24l1.804-5.411a2 2 0 0 1 1.265-1.265z"}],["$","circle","1mglay",{"cx":"12","cy":"12","r":"10"}],"$undefined"]}],["$","h1",null,{"className":"text-6xl font-bold text-white","children":"Strategic Recommendations"}]]}],["$","div",null,{"className":"flex-1 min-h-0 flex flex-col p-6 gap-4","children":[["$","div",null,{"className":"flex-none text-center","children":[["$","p",null,{"className":"text-2xl text-gray-300","children":"Prioritized action plan for successful market entry and sustained competitive advantage"}],["$","p",null,{"className":"text-xl font-bold text-blue-400 mt-1","children":"2025-2030 Strategic Roadmap"}]]}],["$","div",null,{"className":"flex-1 min-h-0 flex flex-col gap-4 justify-around","children":[["$","div",null,{"className":"flex gap-6 bg-slate-800/90 p-4 rounded-lg border-l-4 border-red-400 items-center","children":[["$","div",null,{"className":"flex-none flex flex-col items-center w-32","children":[["$","div",null,{"className":"w-16 h-16 bg-gradient-to-r from-red-500 to-orange-500 rounded-full flex items-center justify-center","children":["$","p",null,{"className":"text-3xl font-bold","children":"1"}]}],["$","p",null,{"className":"text-lg font-bold text-red-400 mt-2","children":"Critical"}]]}],["$","div",null,{"className":"flex-1 min-w-0","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-2","children":"Commercialization & Market Access"}],["$","div",null,{"className":"grid grid-cols-2 gap-x-6 gap-y-2","children":[["$","p",null,{"className":"text-xl","children":"Aggressive U.S. launch with \"first-and-only\" messaging."}],["$","p",null,{"className":"text-xl","children":"Robust patient assistance for <30-day prescription-to-infusion."}],["$","p",null,{"className":"text-xl","children":"Secure favorable formulary position with value-based contracts."}],["$","p",null,{"className":"text-xl","children":"Build real-world evidence registries for diverse populations."}]]}],["$","div",null,{"className":"mt-2 bg-red-500/20 px-3 py-1 rounded-md inline-block","children":["$","p",null,{"className":"text-base font-bold text-red-300","children":"Timeline: 2025-2026"}]}]]}]]}],["$","div",null,{"className":"flex gap-6 bg-slate-800/90 p-4 rounded-lg border-l-4 border-blue-400 items-center","children":[["$","div",null,{"className":"flex-none flex flex-col items-center w-32","children":[["$","div",null,{"className":"w-16 h-16 bg-blue-500 rounded-full flex items-center justify-center","children":["$","p",null,{"className":"text-3xl font-bold","children":"2"}]}],["$","p",null,{"className":"text-lg font-bold text-blue-400 mt-2","children":"High Priority"}]]}],["$","div",null,{"className":"flex-1 min-w-0","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-2","children":"Geographic & Indication Expansion"}],["$","div",null,{"className":"grid grid-cols-2 gap-x-6 gap-y-2","children":[["$","p",null,{"className":"text-xl","children":"Submit for EU/UK approval for +$250M peak sales."}],["$","p",null,{"className":"text-xl","children":"Launch trials in earlier-stage cSCC to expand population 3-5x."}],["$","p",null,{"className":"text-xl","children":"Explore combination therapies with radiation & other inhibitors."}],["$","p",null,{"className":"text-xl","children":"Leverage Sun Pharma network for APAC entry (Japan, Australia)."}]]}],["$","div",null,{"className":"mt-2 bg-blue-500/20 px-3 py-1 rounded-md inline-block","children":["$","p",null,{"className":"text-base font-bold text-blue-300","children":"Timeline: 2026-2028"}]}]]}]]}],["$","div",null,{"className":"flex gap-6 bg-slate-800/90 p-4 rounded-lg border-l-4 border-green-400 items-center","children":[["$","div",null,{"className":"flex-none flex flex-col items-center w-32","children":[["$","div",null,{"className":"w-16 h-16 bg-green-500 rounded-full flex items-center justify-center","children":["$","p",null,{"className":"text-3xl font-bold","children":"3"}]}],["$","p",null,{"className":"text-lg font-bold text-green-400 mt-2","children":"Strategic"}]]}],["$","div",null,{"className":"flex-1 min-w-0","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-2","children":"Long-Term Competitive Positioning"}],["$","div",null,{"className":"grid grid-cols-2 gap-x-6 gap-y-2","children":[["$","p",null,{"className":"text-xl","children":"Develop AI biomarker tools for patient selection."}],["$","p",null,{"className":"text-xl","children":"Partner for companion diagnostic co-development."}],["$","p",null,{"className":"text-xl","children":"Invest in lifecycle management to mitigate biosimilar competition."}],["$","p",null,{"className":"text-xl","children":"Build loyalty via digital engagement platforms."}]]}],["$","div",null,{"className":"mt-2 bg-green-500/20 px-3 py-1 rounded-md inline-block","children":["$","p",null,{"className":"text-base font-bold text-green-300","children":"Timeline: 2027-2030"}]}]]}]]}]]}]]}],["$","div",null,{"className":"flex-none p-4 text-right","children":["$","p",null,{"className":"text-xl text-gray-400","children":"9"}]}]]}]}],null],null],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children","9","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/8d323862949ffad9.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","className":"dark","children":["$","body",null,{"className":"__className_f367f3 h-1080px w-1920px","children":[["$","$4",null,{"fallback":null,"children":[["$","$L5",null,{}],["$","$L6",null,{}]]}],["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]]}]}]],null],null],["$L7",null]]]]
7:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Unloxcyt Market Survey - Interactive Presentation"}],["$","meta","3",{"name":"description","content":"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"}],["$","meta","4",{"name":"next-size-adjust"}]]
1:null
